XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.1

Nature of Operations - Narrative (Details) $ in Billions	3 Months Ended	56 Months Ended
	Mar. 31, 2025 productCandidate	Mar. 31, 2025 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of product candidates approved by the FDA	3
Non-dilutive funding | $		$ 1.4
Number of proprietary product candidates advancing in clinical development	3

X

- Definition

Non-dilutive funding

+ References

No definition available.

+ Details

Name:	mgnx_NonDilutiveFunding
Namespace Prefix:	mgnx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Number Of Product Candidates Approved By The Food And Drug Administration

+ References

No definition available.

+ Details

Name:	mgnx_NumberOfProductCandidatesApprovedByTheFoodAndDrugAdministration
Namespace Prefix:	mgnx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number Of Proprietary Product Candidates Advancing In Clinical Development

+ References

No definition available.

+ Details

Name:	mgnx_NumberOfProprietaryProductCandidatesAdvancingInClinicalDevelopment
Namespace Prefix:	mgnx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration